Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Group Holdings Regulatory News (FSG)

Share Price Information for Foresight Group Holdings (FSG)

Share Price is delayed by 15 minutes
Get Live Data
431.00    -1.00 (-0.23%)
Bid:
432.00
Ask:
434.50
Spread: 2.50 (0.579%)
Market Cap: £479.45m
FSG Live PriceLast checked at - London Stock Exchange

Intraday Foresight Group Holdings Share Chart

Form 8.3 - Focus Solutions Group Plc

15 Dec 2010 13:52

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed: TRAFALGAR ASSET MANAGERS GROUP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FOCUS SOLUTIONS GROUP PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: 14 December 2010
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? NO. (Not disclosing on behalf of any other party to the offer).

If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 10p ORDINARY

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Derivatives (other than options): 319,500 1.06
(3) Options and agreements to purchase/sell:

TOTAL:

319,500 1.06

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
10p ORDINARY CFD INCREASING A LONG POSITION 50,000 137.137

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 15 December 2010
Contact name: Laurena Oledimmah
Telephone number: 020 7534 6024

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2010

Date   Source Headline
20th Apr 20107:00 amRNSTrading Update
7th Apr 20107:00 amRNSGlobal Contract Win
26th Mar 20107:00 amRNSHolding(s) in Company
2nd Mar 20107:00 amRNSContract win
8th Jan 20107:00 amRNSContract Extension with Assureweb
1st Dec 20097:00 amRNSInterim Results
19th Nov 20097:00 amRNSUS patent granted for focus:technology software
5th Nov 20097:00 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSContract Win
4th Nov 20097:00 amRNSTrading Update
2nd Oct 20095:05 pmRNSAdditional Listing and Total Voting Rights
22nd Sep 20097:00 amRNSSuccessful cancellation of share premium account
26th Aug 20099:30 amRNSDirector/PDMR Shareholding
6th Aug 20091:25 pmRNSResult of General Meeting
6th Aug 20091:20 pmRNSResult of AGM
21st Jul 20097:00 amRNSAgreement with Mastek
6th Jul 200911:13 amRNSCapital Reorganisation
3rd Jul 20097:00 amRNSExercise of Options, Issue of Equity & TVR
30th Jun 20099:19 amRNSAdditional Listing and Total Voting Rights
24th Jun 20097:00 amRNSBoard Appointment
23rd Jun 20097:00 amRNSFocus launches new distribution platform
10th Jun 20097:00 amRNSPreliminary Results
26th May 20097:00 amRNSNotice of Results
28th Apr 20099:55 amRNSHolding(s) in Company
21st Apr 20097:00 amRNSTrading Update
31st Mar 20097:00 amRNSDirector Shareholdings in Company
6th Feb 20097:00 amRNSAdditional Listing and Total Voting Rights
21st Jan 20097:00 amRNSAppointment of Sales Director - Wealth Management
19th Jan 20097:00 amRNSContract win
5th Jan 20091:00 pmRNSDirector/PDMR Shareholding
24th Dec 20087:00 amRNSNew contract win
23rd Dec 20089:09 amRNSAcquisition
23rd Dec 20087:00 amRNSDirectorate Change
4th Dec 20087:00 amRNSContract Extension with HSBC
26th Nov 20087:00 amRNSInterim Results
19th Nov 20087:00 amRNSNotice of Results
3rd Nov 20084:13 pmRNSHolding(s) in Company
21st Oct 20087:00 amRNSContract Win
13th Oct 20087:00 amRNSTrading Update
2nd Oct 20084:25 pmRNSReplacement:Notification of Director Shareholdings
2nd Oct 20087:00 amRNSNotification of Director Shareholdings
24th Sep 20087:00 amRNSContract Win
13th Aug 200810:09 amRNSReseller's Agreement with Pho
13th Aug 200810:09 amRNSReseller's Agreement with Pho
11th Aug 20084:10 pmRNSHolding(s) in Company
4th Aug 20087:00 amRNSStrategic Alliance
30th Jul 20087:00 amRNSAGM Statement
28th Jul 20082:04 pmRNSHolding(s) in Company
17th Jun 20087:00 amRNSFinal Results
19th May 20087:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.